D.E. Shaw & Co’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,890
Closed -$240K 3480
2024
Q3
$240K Sell
12,890
-7,788
-38% -$145K ﹤0.01% 2763
2024
Q2
$344K Sell
20,678
-17,142
-45% -$285K ﹤0.01% 2631
2024
Q1
$657K Buy
37,820
+26,836
+244% +$466K ﹤0.01% 2303
2023
Q4
$172K Buy
+10,984
New +$172K ﹤0.01% 2710
2021
Q2
Sell
-2,681
Closed -$1.44M 3810
2021
Q1
$1.44M Buy
+2,681
New +$1.44M ﹤0.01% 1989